New COPD drug candidate AN01 begins first human safety tests
NCT ID NCT07554365
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study is testing a new inhaled medicine called AN01 in 24 healthy adults. The goal is to check if it is safe and how the body processes it. This study does not aim to treat any disease; it is a first step to see if the drug is safe enough to test in people with COPD later.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS STUDY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Site 103
RECRUITINGAdelaide, South Australia, 5000, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can eye movements reveal the Brain's visual priorities?
- Can a new experimental pill be safely given to people?
- A new eye on the brain: could this tracer unlock Addiction's secrets?
- First look: can a new drug candidate pass early safety tests in humans?
- A painless, contact-free vibration sensor may detect hidden heart and lung problems
- Can a Two-Pathway pill improve ED treatment? a new trial puts the combo to the test